Fiorella Krapp Lopez

1. Krapp F, Ozer EA, Qi C, Hauser AR. Case Report of an Extensively Drug-Resistant Klebsiella pneumoniae Infection with Genomic Characterization of the Strain and Review of Similar Cases in the United States. Open Forum Infectious Diseases, Volume 5, Issue 5, 1 May 2018, ofy074, https://doi.org/10.1093/ofid/ofy074

2. Krapp F, Morris AR, Ozer EA, Hauser AR. Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Strains from Patients with Necrotizing Skin and Soft Tissue Infections. Sci Rep. 2017 Oct 19;7(1):13533. doi: 10.1038/s41598-017-13524-8.

3. Krapp F, Grant JL, Sutton SH, Ozer EA, Barr VO. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation. Int J Antimicrob Agents. 2017 Jun;49(6):770-773. doi: 10.1016/j.ijantimicag.2017.01.018. Epub 2017 Apr 4.

4. Ozer EA, Morris AR, Krapp F, Henry CS, Tyo KE, Lathem WW, Hauser AR. Draft Genome Sequence of a Multidrug-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Isolate from a Clinical Source. Genome Announc. 2016 May 26;4(3). pii: e00422-16. Cited in PubMed; PMID: 27231362.

5. Krapp Lopez F, Miley M, Taiwo B. Mycobacterium arupense as an Emerging Cause of Tenosynovitis. Emerg Infect Dis. 2016 Mar;22(3):559-61. Cited in PubMed; PMID: 26890501.

6. Zamudio C, Krapp F, Choi HW, Shah L, Ciampi A, Gotuzzo E, Heymann J, Seas C, Brewer TF. Public Transportation and Tuberculosis Transmission in a High Incidence Setting. PLoS One 10(2): e0115230. eCollection 2015. Cited in PubMed; PMID: 25706530.

7. Shah L, Choi H, Berrang Ford L, Henostroza G, Krapp F, Zamudio C, Heymann J, Kaufman J, Ciampi A, Seas C, Gotuzzo E, Brewer T. Geographic Predictors of Primary Multidrug Resistant Tuberculosis Cases in an Endemic Area of Lima, Peru. Int J Tuberc Lung Dis. 2014 Nov;18(11):1307-14. Cited in PubMed; PMID: 25299862.

8. Ponce M, Ugarte-Gil C, Zamudio C, Krapp F, Gotuzzo E, Seas C. Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru. Trans R Soc Trop Med Hyg. 2012 Aug;106(8):508-10. Epub 2012 Jun 26. Cited in PubMed; PMID: 22742941.

9. Otero L, Krapp F, Tomatis C, Zamudio C, Matthys F, Gotuzzo E, Van der Stuyft P, Seas C. High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors. PLoS One. 2011;6(10):e26276. Epub 2011 Oct 27. Cited in PubMed; PMID: 22046266

10. Brewer TF, Choi HW, Seas C, Krapp F, Zamudio C, Shah L, Ciampi A, Heymann SJ, Gotuzzo E. Self-reported risks for multiple-drug resistance among new tuberculosis cases: implications for drug susceptibility screening and treatment. PLoS One. 2011;6(10):e25861. Epub 2011 Oct 14. Cited in PubMed; PMID: 22022459

11. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, and Perkins MD. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. New England Journal of Medicine. 2010 Sep; 363(11): 1005-1015. Cited in PubMed; PMID: 20825313.

12. Jacob BG, Krapp F, Ponce M, Gotuzzo E, Griffith DA, Novak RJ. Accounting for autocorrelation in Multi-Drug Resistant Tuberculosis predictors using a set of Parsimonious Orthogonal Eigenvectors aggregated in geographic space. Geospatial Health. 2010 May; 4(2): 201-217. Cited in PubMed; PMID: 20503189.

13. Krapp F, Veliz JC, Cornejo E, Gotuzzo E, Seas C. Bodyweight gain to predict treatment outcome in patients with pulmonary tuberculosis in Peru. International Journal of Tuberculosis and Lung Disease. 2008 Oct; 12(10): 1153-1159. Cited in PubMed; PMID: 18812045.